Skip to main content
. 2022 Aug 22;2022:4646245. doi: 10.1155/2022/4646245

Figure 3.

Figure 3

SB treatment was associated with reductions in intestinal inflammation in DM model mice. Upon experimental termination, levels of intestinal (a) TNF-α, (b) IL-1β, (c) IL-6, (d) IL-17, (e) IL-10, and (f) TGF-β were measured. n = 6/group; ∗∗P < 0.01 vs. control and ##P < 0.01 vs. DM group.